Menu
Washingtoner
  • Home
  • Health
  • Boeing
  • Daryl Guberman
  • Aerospace
  • Technology
  • Business
  • Lifestyle
  • ANSI-ANAB
Washingtoner

Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
Washingtoner/10277008

Trending...
  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
  • Tacoma: City Council Takes Steps to Further Activate and Support High-Investment Corridors
  • Spokane: Child Injured in Basement Fire Reminds About Youth Fire Setting
Laboratory Testing for Product Validation BSR Labs Juventix PRP Study Table Juventix Packaging With Tubes Juventix Regenerative Medical, LLC
TAMPA, Fla. - Washingtoner -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.

The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.

Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
  • 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
  • 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
  • Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
  • Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
  • Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
"The inclusion of Juventix PRP in a peer-reviewed study underscores our commitment to delivering scientifically validated, high-quality regenerative solutions," said Lance Liberti, CEO of Juventix Regenerative Medical. "Our focus on innovation ensures practitioners can trust Juventix PRP for consistent, superior patient outcomes."

More on Washingtoner
  • Spokane: SPD is Seeking Public's Assistance in Locating Dangerous Offender
  • Spokane: Flags to be Lowered for Memorial Day
  • Color Card Administrator Highlights Growing Enterprise Demand for Operational Infrastructure in Business Card Identity Governance
  • American Properties Celebrates Grand Opening and Ribbon Cutting Ceremony at Heritage at South
  • Crosswalk Ministries USA Announces 2026 Child and Family Well-Being Conference in Stockbridge, Georgia

Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/

About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.

For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777

More on Washingtoner
  • Research reveals "The Borderless Pay Standard," a 48-point gap between multinational employers and workers on transparent pay expectations
  • Global.ai Appoints Freedomtech Solutions as Specialist Partner for Agentic AI
  • Spokane: SPD Involved in a Use of Deadly Force on North Cincinnati St
  • Spokane Police, Urban Native Organizations Sign MOU to Strengthen Relationships and Communication
  • Tacoma: Murder Arrest Made in Connection to April Missing Person Investigation

✉️ Email:
hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.

Media Contact
Lance Liberti
***@juventix.com
866-693-4777


Source: Juventix Regenerative Medical, LLC

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Lick Introduces Pineapple Flavored Massage Oil — A Tropical Date Night Favorite Available on Amazon
  • FutureLot Powers ADU Wizard for Massachusetts Clean Energy Center's Statewide ADU Resource Center
  • ICT Innovations Releases ICTPBX Community Edition as Open Source Under Mozilla Public License 2.0
  • Spokane: City Closures Planned for Memorial Day
  • Spokane: Child Injured in Basement Fire Reminds About Youth Fire Setting
  • Maryland Personal Injury Firm Earns National Recognition in 2026 ELA Awards
  • Children's Author Releases Second Inspiring Career Book
  • Robert J. Bradshaw's AYE is a Gripping Dual Reality Thriller Exploring the Increasingly Blurred Line Between Humanity and Technology
  • Bangxing Silicone Revolutionizes Silicone Baby Product Partnerships: Low MOQ Support + VIP Long-Term Win-Win Programs
  • SteelTree Announces Launch of Its Operational Decision Intelligence Service
  • Advanced AI Capabilities Reflected by Upcoming Company Name and Stock Symbol Change for Evolving Pre-Owned Boat Dealer: Off The Hook YS: N Y S E: OTH
  • AI-Driven Defense Expansion, Autonomous Systems and Israeli Aerospace Manufacturing Platform: VisionWave Holdings (N A S D A Q: VWAV)
  • AI Predicts the Most Likely 2026 FIFA World Cup Winner
  • The AI Production Shift: Why Game Development Is Entering Its Most Accelerated Phase
  • World-First AI Humanoid Robot Debuts on Cherie Barber's Ground-breaking Australian Reno Show
  • New Survey Reveals America's Most Feared Bridges for Cyclists — Golden Gate Tops the List
  • Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
  • NaturismRE Launches Structured Nudism & Naturism Encyclopedia, Aiming to Reframe Public Understanding
  • AI Is Closing the Gap Between Offshore Virtual Assistants and Onshore Staff
  • CCHR Highlights Concerns Over Coercive and Failed $140 Billion Mental Health Practices at Psychiatric Convention
_catLbl0 _catLbl1

Popular on Washingtoner

  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • Freedomtech Solutions creates 'Global Data Centre Network (IDCN)'
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Axencis Launches Performance Partnership for Brand Protection
  • Project Pretzel Introduces a New System for Running Renovation Projects with Built In Contracts and Real Time Execution
  • Spokane: Abor Day Celebration 2026
  • Five-star Review for Berklee School of Music Textbook
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • Advanced TeleSensors Appoints AgeTech Innovator Tiffany Wey, MBA as Vice President of Sales & Marketing

Similar on Washingtoner

  • D.R. Crotzer Announces A New Science Fiction Book Series Exploring Life Energy, Dreams, and the Mystery of Existence
  • Crosswalk Ministries USA Announces 2026 Child and Family Well-Being Conference in Stockbridge, Georgia
  • Snap Supplements Releases Results of 90-Day Prostate Health Open-Label Pilot Study
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • Lick Introduces Pineapple Flavored Massage Oil — A Tropical Date Night Favorite Available on Amazon
  • Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
  • NaturismRE Launches Structured Nudism & Naturism Encyclopedia, Aiming to Reframe Public Understanding
  • CCHR Highlights Concerns Over Coercive and Failed $140 Billion Mental Health Practices at Psychiatric Convention
  • Fyt-02 Launches on Kickstarter The Smart Sensor That Turns Any Chair Into a Posture & Movement Track
  • Pediatrician Launches "Confessions of a Detective Doctor" Children's Book Series
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute